Orchestra BioMed Holdings, Inc. (OBIO) Return on equity 2022–2025
Orchestra BioMed Holdings, Inc. (OBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-98.4%FY2025 · since FY2022: -64.0% → -98.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -98.4% | +86.8 pp |
| FY2024 | -185.2% | -113.0 pp |
| FY2023 | -72.2% | -8.2 pp |
| FY2022 | -64.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice